Characterisation of tumor microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact. An OCTIPS Consortium study.

Ilary Ruscito, Dan Cacsire Castillo-Tong, Ignace Vergote, Iulia Ignat, Mandy Stanske, Adriaan Vanderstichele, Jacek Glajzer, Hagen Kulbe, Fabian Trillsch, Alexander Mustea, Caroline Kreuzinger, Pierluigi Benedetti Panici, Charles Gourley, Hani Gabra, Marianna Nuti, Eliane T. Taube, Mirjana Kessler, Jalid Sehouli, Silvia Darb-Esfahani, Elena Ioana Braicu

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
JournalBritish Journal of Cancer
DOIs
Publication statusPublished - 29 Jun 2018

Keywords

  • ovarian cancer
  • HGSOC
  • CD31
  • microvessel density
  • MVD
  • VEGF
  • BRCA
  • angiogenesis
  • bevacizumab
  • survival

Access to Document

  • R1 Manuscript OCTIPS MVD clear version- Ruscito 24.04.2018

    This is a pre-copyedited, author-produced version of an article accepted for publication in British Journal of Cancer following peer review. The version of record "Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinicopathological impact (an OCTIPS Consortium study)" is available online at:/doi.org/10.1038/s41416-018-0157-z.

    Accepted author manuscript, 518 KB
  • s41416-018-0157-z - CG

    Note: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0

    Final published version, 1.17 MBLicence: Creative Commons: Attribution (CC-BY)

    Cite this